[DOI] [PMC free article] [PubMed] [Google Scholar] 87.Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Foller M
Seo et al., 2018)
View the current LIV Body GLP-1 offer (official LIV Body page) LIV Body GLP-1 2026 Quick Verification Snapshot - As of June 2026 Platform Name: LIV Body, per brand materials (operated by LivBody HoldCo LLC) Clinical Partner: OpenLoop Healthcare Partners, PC, per LIV Body/OpenLoop published materials (and state-specific affiliated entities) Medication Types Discussed: Compounded semaglutide and compounded tirzepatide, if prescribed by a licensed provider based on individual medical evaluation Starting Price: Brand-stated pricing includes semaglutide from $179/month, tirzepatide from $279/month, and a program FAQ stating the LIV Body GLP-1 program starts at $249/month
Until recently, metformin was considered the only first-line agent to treat type 2 diabetes, either alone or in combination with other anti-diabetic medications
Concern over volatility of counts in recent years led to the use of an alternate source for information on firm and industry data
Popular treatments like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro) are available through weight loss clinics, medspas, and telehealth platforms across the city
